着色性干皮病变异型：对阿维A酯的反应
Xeroderma pigmentosum variant: response to etretinate.
作者信息
Berth-Jones J, Graham-Brown R A
机构信息
Department of Dermatology, Leicester Royal Infirmary, U.K.
出版信息
Br J Dermatol. 1990 Apr;122(4):559-61. doi: 10.1111/j.1365-2133.1990.tb14734.x.
Abstract
We report a case of the variant form of xeroderma pigmentosum in whom tumour development was completely suppressed for 22 months by etretinate 25 mg daily.
摘要
我们报告1例着色性干皮病变异型患者，其肿瘤发展被每日25 mg阿维A完全抑制达22个月。
Zotero 插件